Congress overhauled FDA’s regulatory framework for cosmetics as part of the Consolidated Appropriations Act of 2023. The Modernization of Cosmetics Regulation Act (MoCRA) gave new regulatory authorities to FDA under Chapter VI of the Federal Food, Drug, and Cosmetic Act (FD&C Act). In this webinar, speakers will discuss the new regulatory framework for cosmetics and key provisions for the cosmetics industry, such as facility registration, product listing, mandatory adverse reporting, safety substantiation, mandatory allergen labeling, mandatory recall authority, and current good manufacturing practices (CGMPs) for cosmetics.

Get Access

  • +$100 for nonmembers


Linda M. Katz, Director, Office of Cosmetics and Color, FDA-CFSAN
Surya Kundu, Associate, Steptoe & Johnson LLP
Anand Natarajan, Associate Counsel, Estee Lauder Companies
Moderated by Jessica O’ Connell, Partner, Covington & Burling LLP

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content